Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 10, 2021 - The FDA approved AbbVie’s Mavyret (glecaprevir/pibrentasvir).
Download PDF
Return to publications
